Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.
about
Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIVInhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System.Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy.PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy.HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
P2860
Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dolutegravir in HIV-2-Infected ...... French Named Patient Program.
@en
type
label
Dolutegravir in HIV-2-Infected ...... French Named Patient Program.
@en
prefLabel
Dolutegravir in HIV-2-Infected ...... French Named Patient Program.
@en
P2093
P2860
P50
P356
P1476
Dolutegravir in HIV-2-Infected ...... French Named Patient Program.
@en
P2093
Benoit Visseaux
Claudine Duvivier
Marie-Aude Khuong-Josses
Marina Karmochkine
Pauline Campa
Roland Tubiana
Tuna Lukiana
P2860
P304
P356
10.1093/CID/CIV124
P407
P577
2015-02-17T00:00:00Z